# Glucophage XR® Observational Study

> **NCT01336673** · — · TERMINATED · sponsor: **Merck KGaA, Darmstadt, Germany** · enrollment: 518 (actual)

## Conditions studied

- Diabetes Mellitus Type 2
- GI Side Effect

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01336673
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2011-06
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 518 (ACTUAL)
- **Why stopped:** The study was scheduled for completion February 2013. Because of difficulties encountered in completing the trial the study was terminated by sponsor June 2013.
- **Last updated:** 2014-06-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01336673

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01336673, "Glucophage XR® Observational Study". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01336673. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*